Stocks-GOSS-Gossamer Bio Inc

GOSS Gossamer Bio Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Gossamer Bio Inc's revenues decreased by NaN and amounted to 0.00. Net income increased by 1.98% to -229.38M. Net assets decreased by NaN to N/A and EPS increased from -3.13 to -2.71.
GOSS's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
N/A
Operating Margin
N/A
Return On Investment
-68.66%